Male adeno never smoker

Views:
 
     
 

Presentation Description

No description available.

Comments

Presentation Transcript

Case Mr M : 

Case Mr M FICTITIOUS CASE FOR DEMONSTRATION PURPOSES ONLY

Mr M : 

Mr M 52 year old male, never smoker WHO PS 1 Presented May 2002 8 month history cough 4 month history left shoulder pain No response to antibiotics CXR- “left basal consolidation”

Mr M Investigations : 

Mr M Investigations Bronchoscopy normal CT Thorax/Abdo 3.7 cm lesion in left upper lobe Multiple enlarged mediastinal nodes, right paratracheal, pretracheal and subcarinal Multiple contralateral parenchymal nodules Left pleural effusion Pleura within effusion appears thickened

Mr M CT Scan : 

Mr M CT Scan

Mr M Operative findings : 

Mr M Operative findings Left VATS/Pleurodesis/ transthoracic US 2300 mls pleural effusion Multiple nodular seedings parietal/visceral pleura/diaphragm/pericardium Biopsy of pleural nodules Talc pleurodesis

Mr M Pathology : 

Mr M Pathology Moderate to poorly differentiated adenocarcinoma in keeping with a lung primary CK7+ve, CK20 +ve, TTF1+ve, Ca125 +ve, focally ER +ve but GCDFP –ve

Questions…… : 

Questions……

Treatment options? : 

Treatment options? Platinum doublet, (which?) Platinum doublet + Bevacizumab Platinum doublet + Cetuximab Erlotinib option (evidence?) Other ?

Mr M June 2007 after 4 cycles gemcitabine/platinum…. : 

Mr M June 2007 after 4 cycles gemcitabine/platinum….

Mr M : 

Mr M Received 4 cycles of platinum doublet chemotherapy Partial response on RECIST criteria Recurrence October 2002 (7 month gap)

Treatment options ? : 

Treatment options ? Pemetrexed Docetaxel Erlotinib Re-treat with platinum doublet Avastin Cetuximab Other ?

Mr M Treatment : 

Mr M Treatment 4 cycles 2nd line chemotherapy completed March 2003 CT shows stable disease Clinically well until July 2003 Pain in left ribs and back

August 2003 : 

August 2003

Treatment options? : 

Treatment options? Radiotherapy Pemetrexed Docetaxel Erlotinib Alternate platinum doublet Bevacizumab Cetuximab Other ?

Other factors to influence the choice of treatment……… : 

Other factors to influence the choice of treatment……… Performance Status….. Histology…. Smoking status…. Other….?